Denmark· DK-28106459820
Voraxaze
A glucarpidase product containing glucarpidase, registered in Denmark by SERB SAS. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Glucarpidase is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AF09 (glucarpidase), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Glucarpidase · ATC V03AF09
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Glucarpidase
- Manufacturer
- SERB SAS
- Country
- Denmark (DK)
- ATC code
- V03AF09
- ATC class
- Glucarpidase
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106459820
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for glucarpidase.
Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucarpidase · interactions on record
8 records
- 8 moderate
Most severe, free to view
- TrimethoprimJ01EA01moderate
- PemetrexedL01BA04moderate
- PralatrexateL01BA05moderate
- TrimetrexateP01AX07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AF09
Glucarpidase, as other registers publish it.
- NorwayVoraxazeSERB SAS
- IcelandVoraxazeSERB SAS
- FinlandVoraxazeSerb
- PolandVoraxazeSERB SAS
- United StatesVoraxazeBTG International Inc.
- CzechiaVORAXAZESERB SAS, Paříž
- IrelandVoraxaze 1,000 units powder for solution for injectionSerb S.A.S.
- United KingdomVoraxaze 1,000unit powder for solution for injection vialsProtherics Medicines Development Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f037afaf-f035-41be-9dda-cd4453d4d475 GET /v1/drugs/f037afaf-f035-41be-9dda-cd4453d4d475?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til injektionsvæske, opløsning",
"source": "dkma",
"strength": "1000 E",
"auth_role": "MOD",
"dk_drugid": "28106459820",
"substance": "Glucarpidase",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44572"
}See everything about glucarpidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.